Emcure Pharmaceuticals Ltd

EMCURE

Company Profile

  • Business description

    Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women’s Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.

  • Contact

    Plot No. P-1 and P-2, IT-BT Park
    Phase II, M.I.D.C.
    Hinjawadi
    PuneMH411 057
    IND

    T: +91 2035070033

    https://www.emcure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    11,474

Stocks News & Analysis

stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks

Bapcor is paying for the sins of its past

Shares plunged over 17% after reporting disappointing results.
stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,390.1016.400.17%
CAC 408,243.2737.200.45%
DAX 4024,320.3661.560.25%
Dow JONES (US)46,706.58515.971.12%
FTSE 1009,439.9036.330.39%
HKSE26,027.55168.720.65%
NASDAQ22,990.54310.571.37%
Nikkei 22549,316.06130.560.27%
NZX 50 Index13,377.8532.890.25%
S&P 5006,735.130.000.00%
S&P/ASX 2009,094.7018.800.21%
SSE Composite Index3,916.3352.441.36%

Market Movers